Benzinga
Benzinga
Benzinga
venerdì, settembre 25

MediciNova Inc

MNOVNASDAQ
Trade with Public
Trade with Public
$2.58
-0.07-2.64%
In chiusura: Sep 25, 5:00 PM EST
$2.54
-0.0379-1.47%
Post-mercato: 6:39 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

MediciNova Analyst Price Targets

Wall Street analyst price targets and consensus rating for MediciNova (MNOV).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$7Upside to Avg. PT+183.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 17, 2026Roth CapitalBoobalan PachaiyappanInitiateBuy$6
May 4, 2026D. Boral CapitalJason KolbertMaintainedBuy$9
More with Benzinga EdgeGet Access

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.
Avi Kapoor

PRO
Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.
Benzinga Newsdesk

This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts changed outlook for top names like SUNB, SLDP, ZVRA, COHU, and MNOV. See analyst ratings page for more info. Consider buying COHU stock.
Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved